Literature DB >> 17257359

Complications associated with the development of bacteremia with Staphylococcus aureus.

Laura Troidle1, Thomas Eisen, Lisa Pacelli, Fredric Finkelstein.   

Abstract

Access-related infections are a leading cause of morbidity and mortality among hemodialysis patients. Staphylococcus aureus bacteremia accounts for 25% of these episodes. Nissenson et al., found that 20.7% of the patients developing S. aureus bacteremia had infectious complications as well as hospital readmissions related to the S. aureus bacteremia. This retrospective analysis did not determine whether the S. aureus bacteremia was access related, nor how each episode was treated. We have prospectively collected a database of all access-related S. aureus bacteremia developing in our unit between 1/1/03 and 8/31/05, including the management of the access. Episodes of S. aureus bacteremia with an identifiable source other than the vascular access were excluded. Seventy-two episodes of S. aureus bacteremia were identified; 54 developed in patients using a catheter and 18 developed in patients using an arteriovenous graft/fistula. The mean age was 64+/-15 years, and 56% of the patients were Caucasian. All patients were treated with 4 weeks of antibiotics. A total of 6 (8%) deaths and 15 (20.8%) infectious complications related to the S. aureus bacteremia were identified. Infectious complications included endocarditis (4), metastatic infection (7), discitis (3), and a myocardial abscess (1). Seventeen (23.6%) of the patients were readmitted within 30 days of the episode of S. aureus bacteremia; 4 readmissions were related to the S. aureus bacteremia. Five of the 54 catheter patients who developed S. aureus bacteremia expired and 14 developed infectious complications despite the catheter being removed/exchanged in all but one patient. One of the arteriovenous graft patients who developed S. aureus bacteremia expired. We conclude that infectious complications from S. aureus bacteremia are common, as 23.6% of the patients in our study developed an infectious complication. Eight percent of the patients who developed S. aureus bacteremia expired. Strategies to avoid S. aureus bacteremia are needed.

Entities:  

Mesh:

Year:  2007        PMID: 17257359     DOI: 10.1111/j.1542-4758.2007.00156.x

Source DB:  PubMed          Journal:  Hemodial Int        ISSN: 1492-7535            Impact factor:   1.812


  16 in total

1.  Vascular access infections: epidemiology, diagnosis, and management.

Authors:  Jacob A Akoh
Journal:  Curr Infect Dis Rep       Date:  2011-08       Impact factor: 3.725

2.  Henoch-Schönlein purpura due to methicillin-sensitive Staphylococcus aureus bacteremia from central venous catheterization.

Authors:  Simona Uggeri; Fabio Fabbian; Luigi Catizone
Journal:  Clin Exp Nephrol       Date:  2008-01-09       Impact factor: 2.801

3.  Efficacy of Novel Antistaphylococcal Ectolysin P128 in a Rat Model of Methicillin-Resistant Staphylococcus aureus Bacteremia.

Authors:  Shankaramurthy Channabasappa; Murali Durgaiah; Ravisha Chikkamadaiah; Senthil Kumar; Amruta Joshi; Bharathi Sriram
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

Review 4.  Reducing hospital readmissions in patients with end-stage kidney disease.

Authors:  Anna T Mathew; Giovanni F M Strippoli; Marinella Ruospo; Steven Fishbane
Journal:  Kidney Int       Date:  2015-10-14       Impact factor: 10.612

Review 5.  Infectious complications in dialysis--epidemiology and outcomes.

Authors:  Philip Kam-Tao Li; Kai Ming Chow
Journal:  Nat Rev Nephrol       Date:  2011-12-20       Impact factor: 28.314

6.  Sensitization from transfusion in patients awaiting primary kidney transplant.

Authors:  Julie M Yabu; Matthew W Anderson; Deborah Kim; Brian D Bradbury; Calvin D Lou; Jeffrey Petersen; Jerome Rossert; Glenn M Chertow; Dolly B Tyan
Journal:  Nephrol Dial Transplant       Date:  2013-09-05       Impact factor: 5.992

7.  Safety of Staphylococcus aureus four-antigen and three-antigen vaccines in healthy adults: A meta-analysis of randomized controlled trials.

Authors:  Xiaoqun Xu; Houyong Zhu; Huoyang Lv
Journal:  Hum Vaccin Immunother       Date:  2017-12-06       Impact factor: 3.452

Review 8.  Spondylodiscitis in a patient on chronic hemodialysis.

Authors:  Masoud Afshar; Robert F Reilly
Journal:  Nat Rev Nephrol       Date:  2011-08-16       Impact factor: 28.314

9.  Infected prosthetic dialysis arteriovenous grafts: a single dialysis center study.

Authors:  Petr Bachleda; Lucie Kalinova; Petr Utikal; Milan Kolar; Kristyna Hricova; Tatana Stosova
Journal:  Surg Infect (Larchmt)       Date:  2012-12-10       Impact factor: 2.150

10.  Bacteremia associated with tunneled hemodialysis catheters: outcome after attempted salvage.

Authors:  Damien R Ashby; Albert Power; Seema Singh; Peter Choi; David H Taube; Neill D Duncan; Tom D Cairns
Journal:  Clin J Am Soc Nephrol       Date:  2009-08-13       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.